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Q5
Nonalcoholic fatty liver disease (NAFLD) is themostQ6 common liver condition worldwide and is
linkedQ7 largely to obesity and inactivity. Lifestyle modiﬁ-
cation is the primary treatment for NAFLD targeting
dietary change, physical activity, and exercise to facilitate
weight loss and weight loss maintenance.1–3 This has
been shown to reduce steatosis and ameliorate steato-
hepatitis. European Clinical Practice Guidelines for the
management of NAFLD3 highlight the importance of
targeting lifestyle behavior change in all patients with
NAFLD regardless of disease severity. These guidelines
recommend combining dietary restriction and a
progressive increase in aerobic exercise and resistance
training with a focus on tailoring interventions to the
individual patient. Practice guidelines published by the
American Association for the Study of Liver Diseases4
recommend weight loss of at least 3% to 5% of body
weight via hypocaloric diet or diet combined with
increased physical activity but state that these lifestyle
interventions should target patients with nonalcoholic
steatohepatitis. Given the beneﬁts of lifestyle behavior
change, this study explored the perceptions surrounding
clinical care as currently offered to patients with NAFLD.
The aim of this study was to establish whether current
provision of lifestyle behavior change support is
sufﬁcient, whether health care professionals believe they
have the tools to target lifestyle behavior changes
effectively, and how targeting diet and physical activity/
exercise to facilitate weight loss and weight loss main-
tenance in practice can be improved from the perspec-
tive of health care professionals and patients.
Methods
Semistructured qualitative interviews were conducted
with 21 health care professionals from 2 UK National
Health Service Hospital Trusts and 11 UK National Health
Service Clinical Commissioning Groups across a range of
specialties (hepatology, gastroenterology diabetology,
and primary care) and 12 patients diagnosedwith NAFLD.
Interviews were conducted using 2 interview topic guides
developed with reference to the American Association for
the Study of Liver Diseases and the European Association
for the Study of the Liver, European Association for the
Study of Diabetes, European Association for the Study of
Obesity NAFLD guidelines.4,5 They explored perceptions
and experiences of current clinical practice including the
diagnostic process, management of NAFLD, and recom-
mendations for intervention and optimization of the cur-
rent care pathway. All interviews were audio recorded,
transcribed verbatim, and analyzed independently by
2 researchers using directed content analysis. Study
design and reporting were in accordance with the
“consolidated criteria for reporting qualitative research Q8”
checklist.6
Results
Physicians reported that the process for diagnosing
and assessing NAFLD improved after implementation of
local guidelines (Table 1 Q9, subtheme 1.1); however, they
reported that the drivers of referral from Q10primary to
secondary care varied considerably. For example, a
number of primary care physicians referred patients
with abnormal liver test results or abnormal liver im-
aging suspecting NAFLD. They regularly provided a
NAFLD score but requested advice for ongoing manage-
ment and treatment, speciﬁcally about whether further
investigations were required (Table 1, subtheme 1.1).
Once diagnosed, a lack of knowledge and tools to deliver
effective lifestyle behavior change meant that health care
professionals reported monitoring rather than actively
managing NAFLD (eg, annual reviews consisted of
assessing disease progression) (Table 1, subthemes 2.1,
2.2, 3.1, and 3.2). Patients reported a lack of information
provision after diagnosis of NAFLD, speciﬁcally relating
to NAFLD severity. Furthermore, some patients were
Abbreviation used in this paper: NAFLD, nonalcoholic fatty liver disease.
© 2017 by the AGA Institute. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).
1542-3565
http://dx.doi.org/10.1016/j.cgh.2017.06.011
Clinical Gastroenterology and Hepatology 2017;-:-–-
SSU 5.4.0 DTD  YJCGH55293_proof  6 July 2017  5:33 pm  ce DVC
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
Table 1. Illustrative Quotations by Theme From Data Generated by Health Care Professionals and Patients With NAFLD From
Primary and Secondary Care Q12
Illustrative quotations
Q131.0 Theme: diagnosis
1.1 Subtheme: local guidelines
have improved the
diagnostic process
1.2 Subtheme: inadequate
information provision
about what the diagnosis
means
“Guidelines are now more widely used, actually we get quite a lot that come (to secondary care)
with a NAFLD Fibrosis Score already calculated and have done all the tests and then it’s just
a liver biopsy. So the new guidelines have made a big difference. Not everyone’s using them
yet but I think if we give it a couple of years, simple intervention will have made a huge
difference” (HCP-SC2 Q14)
“GP referrals with abnormal liver tests or abnormal liver imaging.suspect that it’s
NAFLD.quite often they’ve done a NAFLD score or something and they’ll say, ‘please
advise on ongoing management and treatment, and do they need further investigations?’”
(HCP-SC7)
“I couldn’t really go into it. It was so brief, what I got off my GP. And I haven’t done much
research into it myself. She did tell me I could Google it and read up about it.But I haven’t.”
(56-year-old male patient)
“They tell you very little really. You know, you just get told that you’ve got fatty liver disease, but
they’ll say a lot of people have fatty liver disease, it’s nothing to worry about—lots of people
live all of their lives, well, most of their lives with fatty liver disease and that’s it.” (67-year-old
female patient)
2.0 Theme: management
2.1 Subtheme: monitoring
vs active management
2.2 Subtheme: general
lifestyle advice rather
than tailored intervention
2.3 Subtheme: monitoring
vs management
2.4 Subtheme: information
provision about NAFLD is
lacking
“I would see them more with a chronic liver disease slant. I don’t think I would ever enter into the
situation where I’m ever actually managing their weight loss or fatty.Yes, I wouldn’t
ever.I’m not sure I could really afford to get too involved in the, kind of, active management
of risk factors and stuff. I would deﬁnitely shun that back to primary care or to the patients
themselves to be honest. I’m quite keen on getting the patient to take the responsibility”
(HCP-SC11)
“I mean that’s the trouble with nonalcoholic fatty liver disease. Apart from lifestyle, there’s not a
lot else to (do treatment wise)” (HCP-SC12)
“Normally you just tell them to lose 10% of their weight and that’s it. There’s no treatments”
(HCP-SC3)
“It’s just a matter of monitoring how you get on. Making sure you’re doing what she’s telling you
to do. The next step would be a consultant, but wouldn’t they give you the same sort of
information?” (56-year-old male patient)
“I had the biopsy, and got the results back from the biopsy to say that they didn’t need to see
me again—but no help, no advice, no: ‘Okay, you are at the early stages.this is what you
need to do so that you don’t progress,’ nothing.” (53-year-old female patient)
“The only thing they said was to try and sort of lose a bit of weight.But, apart from that, no, I’ve
never ever had any advice or anything else.” (67-year-old female patient)
3.0 Theme: recommendations
3.1 Subtheme: training to
improve knowledge of
NAFLD, diagnosis, and
the referral pathway
3.2 Subtheme: training to
improve delivery of
lifestyle interventions
3.1Q15 Subtheme:
information needs
3.2 Subtheme: tailored
support from a
multidisciplinary team
“Probably under treat and under monitor most of these people. We’re very aware that there’s
lots and lots of people have mildly abnormal liver function tests that we never really go into
great detail, as long as it’s stable. So I think there probably is a training need there to know
who it is we should be looking at and when we should be referring them on.” (HCP-PC6)
“The problem with NAFLD is diagnosing it and I think the lack of treatment speciﬁc for NAFLD is
the biggest problem.we’re still coming back to telling them to exercise and lose
weight.we don’t actually even go after trying to make a proper diagnosis because what’s
the point? At the end of the day we’re just saying good diet and exercise” (HCP-SC6)
“I think the lack of understanding in primary care is very evident sometimes and a lot of them
(patients) come very angry because they’ve been accused of drinking alcohol.” (HCP-SC9)
“I think it (increased knowledge) would be beneﬁcial, the fact that when they start to ask me
questions at least possibly I could give them an answer rather than saying, you need to
speak to the (general practitioner) about that one.” (HCP-PC5)
“Skills of motivational interviewing and behavior change are probably where I think there is still
an awful lot of people telling people what to do. And that culture needs to change”
(HCP-PC1)
“Some form of training on motivational interviewing would be really helpful. Because actually if
you can improve the skills of the people who are seeing the patients then it’s more helpful
than doing nothing and it’s less reliant on.someone else doing it. And I think it probably
would help if you’re referring to something like an exercise program you have to have got
somebody on board with that, don’t you?” (HCP-SC8)
“I would have liked for it to have been explained how or why you get it, because they don’t
really.by what I have read sometimes it’s your diet and things like that. And, well, just what
you should do really, just anything.it would be nice to have a leaﬂet just for it to explain, and
things that would help.” (67-year-old female patient)
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advised that NAFLD is nothing to be concerned about
when compared with other health conditions (ie, health
conditions such as diabetes were viewed as more
important) (Table 1, subtheme 1.1). This was particularly
the case in primary care. Patients reported a lack of
support thereafter to manage their condition effectively.
They reported being advised to lose weight but did not
receive any support to do so (Table 1, subtheme 2.1) and
reported not knowing that NAFLD could be improved via
lifestyle modiﬁcation (Table 1, subtheme 3.1). This could
explain in part why the majority of patients rarely
succeed with weight loss in this context. Both participant
groups reported the need for a multidisciplinary team to
support the management of NAFLD, including a range of
lifestyle intervention options that are sensitive to the
needs and preferences of patients and that help to
support long-term behavior change (Table 1, subthemes
3.2 and 4.1–4.3).
Discussion
Although evidence has shown that lifestyle in-
terventions targeting diet and physical activity/exercise
for weight loss are effective for managing NAFLD, and
published clinical guidelines recommend such interven-
tion, we have identiﬁed a substantial disconnect between
guidance and how clinical care is delivered in practice. A
lack of resources and training on how to target lifestyle
behavior change to help manage NAFLD long term
effectively was reported by health care professionals, as
well as the need for a joint way Q11of working across
Table 1. Continued
Illustrative quotations
“Some type of intervention in terms of weight loss and dieting might be quite useful. And
certainly to kind of motivate them to do it regularly. You could have just a kind of nurse
in-between seeing the doctors in the hospital. Or you could take it into the community if there
are so many people who’ve got nonalcoholic fatty liver disease, and develop kind of satellite
clinics, for which you don’t really need a doctor.” (60-year-old male patient)
“I think people work well in groups and support each other, and it is nice to hear other peoples’
experiences, I think that group session would be great.” (53-year-old female patient)
4.0 Theme: service delivery
4.1 Subtheme:
multidisciplinary
team input is important to
tailor management of NAFLD
4.2 Subtheme: tools to support
management of NAFLD
4.3 Subtheme: approach to
management that is ﬂexible
and offers choice
“In any kind of weight loss management we know that better outcomes come from the more
intensive support, the more regular contact, and working through a series of, um, I suppose,
tighter dietary restrictions, as well as accompanying education.” (HCP-SC1)
“Increased access to gyms and appropriate exercise, maybe having a trial of ’look these are
different activities you could try in a nonthreatening environment.’” (HCP-SC2)
“Multidisciplinary team.dietetics.key to delivery. Work on lifestyle change.individuals who
develop NAFLD.are not particularly open to increasing exercise.individuals with fatty liver
lack the conﬁdence to make these changes.giving some advice and enabling people to
make those changes would be useful.psychological support.not uniformly available. In
terms of the exercise.greater links with group exercise sessions.cardiac rehabilitation.
‘Why Weight Q16?’..improving the pathways between these.” (HCP-SC5)
“What I ideally wanted was almost like a one-stop shop. I can foresee a great big clinic with
me, the physio, a dietician, all doing a one-stop appointment for them to go out.” (HCP-SC9)
“Food diaries, pedometers to set people simple goals.to nudge people toward slightly greater
exercise and nudge people slightly lower caloriﬁc intakes. It doesn’t have to be traumatic, in
fact, the less traumatic it is the easier it will be to sustain it.” (HCP-SC5)
“A simple patient information leaﬂet” (HCP-PC4)
“Nice to actually have an exercise and diet plan which is actually tailored to the patient
themselves within an ability for regular review, and somebody to just be able to ring up if
they’re having any issues or any problems. I’m not saying 24 hours.I think personalized
plans are very important, actually, because everybody’s different.somebody who was
properly nutritionally trained. That’s very important.longer appointments with them to
unpick kind of exactly what’s happening, rather than your 10-minute slot where you try to
cover everything.They’d appreciate that kind of thing. I think most patients do.” (HCP-PC4)
“What I would like is to be able to pass the patient on to some sort of lifestyle coach, and then
for the next time I see them to have more data, so that I can look at what their calorie intake
and what their eating habits are, what their pedometer shows, what their self-ﬁlled
questionnaire about their self-efﬁcacy..Yes, that would be useful to have a suite of
information, it would incentivize me to see them again” (HCP-SC10)
“Own gym and swimming pool with a physiotherapist.a dietician to have groups.a
psychologist.always a psychological element to the weight. I think the physiotherapy part,
because these are really big individuals, they can start even seated exercises, arm exercises,
all this sort of thing which I can’t teach them.aqua ﬁt.a kitchen as well for teaching them
how to cook” (HCP-SC6)
HCP-PC, health care professional from primary care; HCP-SC, health care professional from secondary care.
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disciplines to avoid miscommunication to patients.
Patients further reinforced this ﬁnding, indicating that
information and support at the time of diagnosis and
thereafter is severely lacking.
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